A massive new review of multivitamin research gives a clear answer on two of the biggest health questions of middle age: these pills raise your vitamin levels, but they do not stop heart disease.
Quick Take
- A scoping review covering 157 published studies found multivitamins reliably raise folate, B6, and B12 levels in the blood.
- Cardiovascular prevention results came back largely null, matching findings from major federal health reviews.
- One large trial of adults over 65 found a daily multivitamin modestly improved memory and overall brain function.
- Researchers did not run a bias check or combine results into one statistic, so the findings describe patterns rather than prove cause and effect.
What The New Review Actually Found
Researchers Fan, Nelson, and Wallace published their scoping review in the Journal of Dietary Supplements in late October 2026. They pulled together 157 articles: 103 original studies and 54 related reports built on the same research. The goal was simple. Find out what happens, biologically and medically, when healthy people take a daily multivitamin over time.
The clearest finding had nothing to do with disease. People who took multivitamins consistently showed higher blood levels of folate, vitamin B6, and vitamin B12. That part of the story is settled. Multivitamins do what they say on the label when it comes to raising nutrient levels in the bloodstream.
But the authors were careful not to stretch that finding further than it should go. Raising a vitamin number on a lab report is not the same as preventing a heart attack or a stroke. The review states plainly that improved nutrient status does not mean universal disease prevention, and it labels the cardiovascular findings largely null.
The Heart Disease Question Comes Up Empty
This is not a one-study conclusion. The National Institutes of Health reviewed data from more than two million participants, with studies averaging over 11 years of follow-up. Multivitamin use was not linked to lower death rates from cardiovascular disease, lower coronary heart disease risk, or fewer strokes. For heart protection specifically, the evidence lines up against the supplement aisle’s marketing.
That matters because heart disease remains the leading killer of American adults over 40. A daily pill that genuinely cut that risk would be one of the biggest public health wins in decades. The honest reading of the data says multivitamins are not that pill, at least not for a general, healthy adult population.
A Narrower, Real Signal On Memory
Cognitive decline is a different story, though still a modest one. The COSMOS trial followed more than 2,200 adults aged 65 and older for three years. Those assigned to a daily multivitamin scored higher on cognitive tests than those taking a placebo, with the benefit showing up most clearly in memory. The National Institutes of Health highlighted this result in 2023 as a genuine, measurable finding.
The size of that effect matters, though. Researchers measured it as a small statistical shift in test scores, not a dramatic transformation in brain health. It is real, but it is not a cure for dementia, and the review found evidence for preventing dementia itself remains thin and inconsistent.
Why The Review Can’t Settle The Debate
The scoping review has real limits, and the authors do not hide them. They did not formally check the quality or bias of the 157 studies they examined. They also did not run a meta-analysis, the statistical process that combines results from many trials into one reliable number. Without that step, nobody can say exactly how strong the memory benefit really is.
There is also the counting problem. Those 157 publications do not represent 157 separate groups of people. Many of the 54 related reports drew on the same trial participants already covered elsewhere, meaning the underlying evidence pool is smaller than the headline number suggests.
What This Means For Your Medicine Cabinet
Multivitamins are not one standardized pill. Formulations, doses, and participant health all varied across the studies reviewed, which makes it risky to assume a result from one trial applies to every bottle on a pharmacy shelf. A supplement that helped an older adult with low baseline nutrient levels may do little for someone already eating a balanced diet.
The bottom line for readers over 40: a daily multivitamin is a reasonable, low-risk way to shore up nutrient gaps and may offer a small memory benefit later in life. It is not a substitute for the proven basics of heart health, like blood pressure control, exercise, and diet. Common sense still beats a pill for preventing the diseases that matter most.
Readers weighing a daily supplement should talk with their own doctor about personal risk factors and nutrient levels before assuming any one study settles the question for them.
Sources:
youtube.com, ods.od.nih.gov, medicaldialogues.in, news-medical.net, tandfonline.com
